Skip to content

Clinical trials

Phase 2 Macular Degeneration trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Degeneration Phase: Phase 2 Country / region: Germany Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20072
20081
20091
20101
20112
20131
20142
20191
20201
20221
20231
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated3
Recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Allergan3
GlaxoSmithKline2
Alkahest, Inc.1
Bayer1
Galimedix Therapeutics Inc1
Grifols Therapeutics LLC1
Gyroscope Therapeutics Limited1
Janssen Research & Development, LLC1
Novartis Pharmaceuticals1
ONL Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Degeneration17
Geographic Atrophy6
Retinal Diseases3
Eye Diseases2
Retinal Degeneration2
Anetoderma1
Diabetic Retinopathy1
Macular Edema1
Plaque, Amyloid1
Retinal Vein Occlusion1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.